Authors:
BRUERA E
BELZILE M
PITUSKIN E
FAINSINGER R
DARKE A
HARSANYI Z
BABUL N
FORD I
Citation: E. Bruera et al., RANDOMIZED, DOUBLE-BLIND, CROSS-OVER TRIAL COMPARING SAFETY AND EFFICACY OF ORAL CONTROLLED-RELEASE OXYCODONE WITH CONTROLLED-RELEASE MORPHINE IN PATIENTS WITH CANCER PAIN, Journal of clinical oncology, 16(10), 1998, pp. 3222-3229
Authors:
BABUL N
PROVENCHER L
LABERGE F
HARSANYI Z
MOULIN D
Citation: N. Babul et al., COMPARATIVE EFFICACY AND SAFETY OF CONTROLLED-RELEASE MORPHINE SUPPOSITORIES AND TABLETS IN CANCER PAIN, Journal of clinical pharmacology, 38(1), 1998, pp. 74-81
Citation: Cpn. Watson et N. Babul, EFFICACY OF OXYCODONE IN NEUROPATHIC PAIN - A RANDOMIZED TRIAL IN POSTHERPETIC NEURALGIA, Neurology, 50(6), 1998, pp. 1837-1841
Citation: Sj. Jacobson et al., RANDOMIZED TRIAL OF ORAL MORPHINE FOR PAINFUL EPISODES OF SICKLE-CELLDISEASE IN CHILDREN, Lancet, 350(9088), 1997, pp. 1358-1361
Citation: Na. Hagen et N. Babul, COMPARATIVE CLINICAL EFFICACY AND SAFETY OF A NOVEL CONTROLLED-RELEASE OXYCODONE FORMULATION AND CONTROLLED-RELEASE HYDROMORPHONE IN THE TREATMENT OF CANCER PAIN, Cancer, 79(7), 1997, pp. 1428-1437
Authors:
PELOSO P
BELLAMY N
BENSEN W
THOMPSON G
BABUL N
Citation: P. Peloso et al., A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL OF CONTROLLED-RELEASE CODEINE IN OSTEOARTHRITIS OF HIP AND KNEE, Arthritis and rheumatism, 40(9), 1997, pp. 331-331
Authors:
BRUERA E
SEIFERT L
WATANABE S
BABUL N
DARKE A
HARSANYI Z
SUAREZALMAZOR M
Citation: E. Bruera et al., CHRONIC NAUSEA IN ADVANCED CANCER-PATIENTS - A RETROSPECTIVE ASSESSMENT OF A METOCLOPRAMIDE-BASED ANTIEMETIC REGIMEN, Journal of pain and symptom management, 11(3), 1996, pp. 147-153
Authors:
DHALIWAL HS
SLOAN P
ARKINSTALL WW
THIRLWELL MP
BABUL N
HARSANYI Z
DARKE AC
Citation: Hs. Dhaliwal et al., RANDOMIZED EVALUATION OF CONTROLLED-RELEASE CODEINE AND PLACEBO IN CHRONIC CANCER PAIN, Journal of pain and symptom management, 10(8), 1995, pp. 612-623
Authors:
BRUERA E
FAINSINGER R
SPACHYNSKI K
BABUL N
HARSANYI Z
DARKE AC
Citation: E. Bruera et al., CLINICAL EFFICACY AND SAFETY OF A NOVEL CONTROLLED-RELEASE MORPHINE SUPPOSITORY AND SUBCUTANEOUS MORPHINE IN CANCER PAIN - A RANDOMIZED EVALUATION, Journal of clinical oncology, 13(6), 1995, pp. 1520-1527
Authors:
ARKINSTALL W
SANDLER A
GOUGHNOUR B
BABUL N
HARSANYI Z
DARKE AC
Citation: W. Arkinstall et al., EFFICACY OF CONTROLLED-RELEASE CODEINE IN CHRONIC NONMALIGNANT PAIN -A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL-TRIAL, Pain, 62(2), 1995, pp. 169-178
Authors:
BRUERA E
FAINSINGER R
SPACHYNSKI K
BABUL N
HARSANYI Z
DARKE AC
Citation: E. Bruera et al., STEADY-STATE PHARMACOKINETIC EVALUATION OF A NOVEL, CONTROLLED-RELEASE MORPHINE SUPPOSITORY AND SUBCUTANEOUS MORPHINE IN CANCER PAIN, Journal of clinical pharmacology, 35(7), 1995, pp. 666-672
Authors:
HAGEN N
THIRLWELL MP
DHALIWAL HS
BABUL N
HARSANYI Z
DARKE AC
Citation: N. Hagen et al., STEADY-STATE PHARMACOKINETICS OF HYDROMORPHONE AND HYDROMORPHONE-3-GLUCURONIDE IN CANCER-PATIENTS AFTER IMMEDIATE AND CONTROLLED-RELEASE HYDROMORPHONE, Journal of clinical pharmacology, 35(1), 1995, pp. 37-44
Authors:
BABUL N
DHALIWAL H
SLOAN P
ARKINSTALL W
THIRLWELL M
HARSANYI Z
DARKE A
Citation: N. Babul et al., ANALGESIC EFFICACY AND SAFETY OF CONTROLLED-RELEASE CODEINE AND PLACEBO IN CANCER PAIN, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 137-137
Authors:
DARKE A
MOULIN D
PROVENCHER L
LABERGE F
HARSANYI Z
BABUL N
Citation: A. Darke et al., EFFICACY, SAFETY AND PHARMACOKINETICS OF CONTROLLED-RELEASE MORPHINE SUPPOSITORIES AND TABLETS IN CANCER PAIN, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 165-165
Authors:
BABUL N
HAGEN N
THIRLWELL M
DHALIWAL H
HARSANYI Z
DARKE A
Citation: N. Babul et al., STEADY-STATE DISPOSITION OF HYDROMORPHONE AND HYDROMORPHONE-3-GLUCURONIDE IN CANCER-PATIENTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 165-165
Authors:
FRADETTE M
BABICH M
FRIESEN EG
ARCHIBALD JS
BABUL N
Citation: M. Fradette et al., SERUM THEOPHYLLINE PROFILE WITH ONCE-DAILY THEOPHYLLINE (UNIPHYL) FOLLOWING CONVERSION FROM INTRAVENOUS THEOPHYLLINE IN ADULT ASTHMATIC-PATIENTS, Clinical therapeutics, 16(2), 1994, pp. 160-168
Authors:
HAYS H
HAGEN N
THIRLWELL M
DHALIWAL H
BABUL N
HARSANYI Z
DARKE AC
Citation: H. Hays et al., COMPARATIVE CLINICAL EFFICACY AND SAFETY OF IMMEDIATE-RELEASE AND CONTROLLED-RELEASE HYDROMORPHONE FOR CHRONIC SEVERE CANCER PAIN, Cancer, 74(6), 1994, pp. 1808-1816
Authors:
BRUERA ED
MACEACHERN TJ
SPACHYNSKI KA
LEGATT DF
MACDONALD RN
BABUL N
HARSANYI Z
DARKE AC
Citation: Ed. Bruera et al., COMPARISON OF THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF CONTROLLED-RELEASE AND IMMEDIATE-RELEASE METOCLOPRAMIDE FOR THE MANAGEMENT OF CHRONIC NAUSEA IN PATIENTS WITH ADVANCED CANCER, Cancer, 74(12), 1994, pp. 3204-3211
Authors:
FRASER IM
BUTTOO KM
WALKER SE
STEWART JH
BABUL N
Citation: Im. Fraser et al., EFFECTS OF CIMETIDINE AND RANITIDINE ON THE PHARMACOKINETICS OF A CHRONOTHERAPEUTICALLY FORMULATED ONCE-DAILY THEOPHYLLINE PREPARATION (UNIPHYL(R)), Clinical therapeutics, 15(2), 1993, pp. 383-393
Citation: N. Babul et Ac. Darke, DISPOSITION OF MORPHINE AND ITS GLUCURONIDE METABOLITES AFTER ORAL AND RECTAL ADMINISTRATION - EVIDENCE OF ROUTE SPECIFICITY, Clinical pharmacology and therapeutics, 54(3), 1993, pp. 286-292